Circulating tumor DNA/circulating tumor cells and the applicability in different causes induced hepatocellular carcinoma.

Paola Dongiovanni, Luca Valenti, Genetics of nonalcoholic fatty liver disease Metabolism-clinical and Experimental. ,vol. 65, pp. 1026- 1037 ,(2016) , 10.1016/J.METABOL.2015.08.018

Sean P. Cleary, William R. Jeck, Xiaobei Zhao, Kui Chen, Sara R. Selitsky, Gleb L. Savich, Ting-Xu Tan, Michael C. Wu, Gad Getz, Michael S. Lawrence, Joel S. Parker, Jinyu Li, Scott Powers, Hyeja Kim, Sandra Fischer, Maha Guindi, Anand Ghanekar, Derek Y. Chiang, Identification of driver genes in hepatocellular carcinoma by exome sequencing Hepatology. ,vol. 58, pp. 1693- 1702 ,(2013) , 10.1002/HEP.26540

Giovanna Vona, Abdelmajid Sabile, Malek Louha, Veronique Sitruk, Serge Romana, Karin Schütze, Frédérique Capron, Dominique Franco, Mario Pazzagli, Michel Vekemans, Bernard Lacour, Christian Bréchot, Patrizia Paterlini-Bréchot, None, Isolation by Size of Epithelial Tumor Cells : A New Method for the Immunomorphological and Molecular Characterization of Circulating Tumor Cells American Journal of Pathology. ,vol. 156, pp. 57- 63 ,(2000) , 10.1016/S0002-9440(10)64706-2

Kilian Friedrich, Andreas Wannhoff, Stefan Kattner, Maik Brune, Johannes Roksund Hov, Karl Heinz Weiss, Christoph Antoni, Matthias Dollinger, Christoph Neumann-Haefelin, Thomas Seufferlein, Peter Schemmer, Peter Schirmacher, Wolfgang Stremmel, Daniel Nils Gotthardt, PNPLA3 in end-stage liver disease: alcohol consumption, hepatocellular carcinoma development, and transplantation-free survival. Journal of Gastroenterology and Hepatology. ,vol. 29, pp. 1477- 1484 ,(2014) , 10.1111/JGH.12540

F. Xavier Bosch, Josepa Ribes, Ramon Cléries, Mireia Díaz, Epidemiology of Hepatocellular Carcinoma Clinics in Liver Disease. ,vol. 9, pp. 191- 211 ,(2005) , 10.1016/J.CLD.2004.12.009

Silvina Laura Malmassari, Qiang Deng, Hélène Fontaine, Dianne Houitte, François Rimlinger, Valérie Thiers, Bernard Maillere, Stanislas Pol, Marie-Louise Michel, Impact of hepatitis B virus basic core promoter mutations on T cell response to an immunodominant HBx-derived epitope. Hepatology. ,vol. 45, pp. 1199- 1209 ,(2007) , 10.1002/HEP.21594

Xiaoli Chen, Shilpa Lingala, Shiva Khoobyari, Jan Nolta, Mark A. Zern, Jian Wu, EPITHELIAL MESENCHYMAL TRANSITION AND HEDGEHOG SIGNALING ACTIVATION ARE ASSOCIATED WITH CHEMORESISTANCE AND INVASION OF HEPATOMA SUBPOPULATIONS Journal of Hepatology. ,vol. 55, pp. 838- 845 ,(2011) , 10.1016/J.JHEP.2010.12.043

Gengming Huang, Joseph D. Krocker, Jason L. Kirk, Shehzad N. Merwat, Hyunsu Ju, Roger D. Soloway, Lucas R. Wieck, Albert Li, Anthony O. Okorodudu, John R. Petersen, Nihal E. Abdulla, Andrea Duchini, Luca Cicalese, Cristiana Rastellini, Peter C. Hu, Jianli Dong, Evaluation of INK4A promoter methylation using pyrosequencing and circulating cell-free DNA from patients with hepatocellular carcinoma Clinical Chemistry and Laboratory Medicine. ,vol. 52, pp. 899- 909 ,(2014) , 10.1515/CCLM-2013-0885

Jean-Yves Douillard, Gyula Ostoros, Manuel Cobo, Tudor Ciuleanu, Rebecca Cole, Gael McWalter, Jill Walker, Simon Dearden, Alan Webster, Tsveta Milenkova, Rose McCormack, Gefitinib Treatment in EGFR Mutated Caucasian NSCLC: Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status Journal of Thoracic Oncology. ,vol. 9, pp. 1345- 1353 ,(2014) , 10.1097/JTO.0000000000000263

Yan Liu, Chung-Chou H. Chang, Gary M. Marsh, Felicia Wu, Population attributable risk of aflatoxin-related liver cancer: systematic review and meta-analysis. European Journal of Cancer. ,vol. 48, pp. 2125- 2136 ,(2012) , 10.1016/J.EJCA.2012.02.009